Category: Joint ventures/collaborations
-
Inhaled Dry-Powder Covid-19 Antibodies in the Works
Two biotechnology companies are developing synthetic antibodies to treat Covid-19 infections formulated as an inhaled dry powder rather than an infusion.
-
FDA to Use Lung Chip Model for Covid-19 Testing
The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infections, and other processes.
-
200M Covid-19 Vaccine Doses Donated to Int’l Effort
Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide.
-
Roche Gains Covid-19 Oral Drug Candidate
Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a oral drug, rather than an infusion.
-
Software Designed to Model, Visualize Brain Circuits
An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits.
-
Covid-19 Vaccine Challenge Trial Underway
Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines.
-
Cancer Center, Biotech Partner on Off-the-Shelf T-Cells
MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells.
-
Individual Cells Explored with Virtual Reality
A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions.
-
Engineered Heart Tissue Mechanisms Probed
A research institute is partnering with a company creating heart tissue patches from stem cells to better understand the details of how the patch works.
-
Biotech, Analytics Companies Partner on Drug Discovery
A biotechnology company and genomics data science enterprise agreed in a multi-year agreement to discover new therapies for up to 20 diseases.